Contributors: Julie Gil, Ph.D., Sarah Kleinstein, Ph.D., Cera Fisher, Ph.D., Dennis Dean Ph.D., and Kristina Clemens Ph.D. During the COVID-19 pandemic, many of us gained first-hand experience of the efficacy of mRNA vaccines. Twenty years of dedicated research in the general application of mRNA vaccines fueled the rapid delivery of …
Exploring the Science Behind Neoantigen Discovery from Mutations to Proteins
calendar_today
October 12, 2023
person
Jeffrey Brabec, PhD, Scientific Partner at Velsera
domain
seven-bridges